Industry
i-SENS, Inc.
Total Trials
3
Recruiting
1
Active
2
Completed
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
Failure Rate
33.3%
1 terminated/withdrawn out of 3 trials
Success Rate
0.0%
-86.5% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed trials have results
Key Signals
1 recruiting1 with results
Enrollment Performance
Analytics
N/A
3(100.0%)
3Total
N/A(3)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (3)
Showing 3 of 3 trials
NCT07296276Not ApplicableRecruiting
Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM
Role: lead
NCT07298850Not ApplicableActive Not Recruiting
A Study on the Effect of CGM Alone on Glycemic Metrics in Type 2 Diabetes Patients Not Using Insulin, Without Additional Interventions
Role: collaborator
NCT05833100Not ApplicableTerminated
Method Comparison/User Evaluation of the i-SENS Self-Monitoring Blood Glucose / β-Ketone System
Role: lead
All 3 trials loaded